Vertex Pharmaceuticals
VRTX
VRTX
1,028 hedge funds and large institutions have $50.1B invested in Vertex Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 201 funds opening new positions, 335 increasing their positions, 364 reducing their positions, and 87 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
11% more funds holding
Funds holding: 928 → 1,028 (+100)
1.34% more ownership
Funds ownership: 89.18% → 90.53% (+1.3%)
8% less repeat investments, than reductions
Existing positions increased: 335 | Existing positions reduced: 364
Holders
1,028
Holding in Top 10
9
Calls
$673M
Puts
$547M
Top Buyers
| 1 | +$926M | |
| 2 | +$302M | |
| 3 | +$227M | |
| 4 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
+$203M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$166M |
Top Sellers
| 1 | -$422M | |
| 2 | -$230M | |
| 3 | -$174M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$171M |
| 5 |
Two Sigma Advisers
New York
|
-$169M |